Daniel W. Muehl
Overview
Daniel W. Muehl received an average of $2M in total compensation, including $417K in salary, at Clovis Oncology from 2016 to 2021. Daniel Muehl also received an average of $239K at Repligen between 2007 and 2008.
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2008
- 2007
Clovis OncologyEVP and Chief Financial Officer
Clovis OncologyEVP and Chief Financial Officer
Clovis OncologyEVP and Chief Financial Officer
Clovis OncologySenior VP of Finance, Principal Accounting Officer, and Principal Financial Officer
Clovis OncologySenior VP of Finance, Principal Accounting Officer, and Principal Financial Officer
Clovis OncologySenior VP of Finance
RepligenChief Financial Officer
RepligenChief Financial Officer
Source: SEC filings on April 27, 2022, April 28, 2021, April 24, 2020, April 26, 2019, April 27, 2018, April 26, 2017, and July 29, 2008.
Related executives
We found 18 more executives who work or worked at Clovis Oncology and Repligen.
Tony Hunt
Repligen
Chief Executive Officer
Patrick Mahaffy
Clovis Oncology
Chief Executive Officer
Jon Snodgres
Repligen
Chief Financial Officer
James Bylund
Repligen
Chief Operating Officer
Ralf Kuriyel
Repligen
Senior Vice President of Research and Development
Christine Gebski
Repligen
Senior Vice President of Filtration &Chromatography
Lindsey Rolfe
Clovis Oncology
Chief Medical Officer
Gillian Ivers-Read
Clovis Oncology
EVP and Chief Regulatory Officer
News
Clovis Oncology CEO Patrick Mahaffy's 2021 pay slips 18% to $2.6M
April 27, 2022
Clovis Oncology CEO Patrick Mahaffy's 2020 pay falls 53% to $3.2M
April 28, 2021
Clovis Oncology CEO Patrick Mahaffy's 2019 pay rises 10% to $6.9M
April 24, 2020
Clovis Oncology CEO Patrick Mahaffy's 2018 pay falls 28% to $6.3M
April 26, 2019